Benjamin Cara L, Melnikova Vladislava O, Ananthaswamy Honnavara N
Department of Immunology, The University of Texas M.D. Anderson Cancer Center, P.O. Box 301402, Unit #902, Houston, TX 77030-1903, USA.
Adv Exp Med Biol. 2008;624:265-82. doi: 10.1007/978-0-387-77574-6_21.
The p53 tumor suppressor gene and gene product are among the most diverse and complex been shown to have a direct correlation with cancer development and have been shown to occur in nearly 50% of all cancers. p53 mutations are particularly common in skin cancers and UV irradiation has been shown to be a primary cause of specific 'signature' mutations that can result in oncogenic transformation. There are certain 'hot-spots' in the p53 gene where mutations are commonly found that result in a mutated dipyrimidine site. This review discusses the role of p53 from normal function and its dysfunction in precancerous lesions, nonmelanoma and melanoma skin cancers. Additionally, molecules that associate with p53 and alter its function to produce neoplastic conditions are also explored in this chapter.
p53肿瘤抑制基因及其基因产物是最多样化和最复杂的之一,已被证明与癌症发展直接相关,并且在几乎50%的所有癌症中都有发生。p53突变在皮肤癌中尤为常见,紫外线照射已被证明是导致特定“特征性”突变的主要原因,这些突变可导致致癌转化。p53基因中存在某些“热点”,在这些位置通常会发现导致二嘧啶位点突变的突变。本综述讨论了p53在癌前病变、非黑色素瘤和黑色素瘤皮肤癌中的正常功能及其功能障碍所起的作用。此外,本章还探讨了与p53相关并改变其功能以产生肿瘤状态的分子。